ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice

Published:2017-08-12 Issue:12 Volume:9 Page:107
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Hofman Paul

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

http://www.mdpi.com/2072-6694/9/8/107/pdf

Reference132 articles.

1. ALKin Lung Cancer: Past, Present, and Future

2. Expanding opportunities for crizotinib resistance in ALK-positive lung cancer patients

3. Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

4. Diagnostic and therapeutic issues for patients with advanced non-small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review)

5. Drug resistance in ALK-positive non-small cell lung cancer patients;Qian;Semin. Cell Dev. Biol.,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy;Current Protein & Peptide Science;2024-09

2. Discovery of novel EGFR-PROTACs capable of degradation of multiple EGFR-mutated proteins;European Journal of Medicinal Chemistry;2024-06

3. Discovery of Novel Egfr-Protacs Overcoming Various Types of Acquired Drugs Resistant;2024

4. Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review;Frontiers in Oncology;2023-11-01

5. Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer;Pharmaceutics;2023-04-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3